Tuberculosis in sub-Saharan Africa: A regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality

Tubercle and Lung Disease

Volumn 77, Issue 3, 1996, Pages 220-225

  Cantwell, M F ^a   Binkin, N J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RATE; MAJOR CLINICAL STUDY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0029780412     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90004-0     Document Type: Article

References (11)

1. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. Population Division, United Nations. World population prospects: the 1992 revision. United Nations publication (Sales number: E.93.XIII.7), New York, 1993.
3. Center for International Research, United States Bureau of the Census. Recent HIV seroprevalence levels: June 1993, Research note number 9. United States Bureau of the Census press, Washington, DC, June 1993.
4. Tuberculosis Programme, World Health Organization. Tuberculosis notification update, July 1992. World Health Organization, Geneva, July 1992.
5. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992; 70: 149-159.
6. Maganu E T, Moeti M R, Khulumani P, Koosimile B S, Sentle C. The annual risk of tuberculosis infection in Botswana: Report of a survey, 1989. Botswana Ministry of Health, 1990.
7. Styblo K. Preliminary report on the second round of the National Tuberculin Survey in Tanzania in the first 19 regions, 1988 - June 1992. International Union Against Tuberculosis and Lung Diseases, Tuberculosis Surveillance Research Unit Progress Report 1992; 2: 113-129.
8. Murray C J L, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention, and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-26.
9. Selwyn P A, Hartel D, Lewis V A et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989; 320: 545-550.
10. Narain J P, Raviglione M C, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-321.
11. Braun M M, Badi N, Ryder R W et al. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis 1991; 143: 501-504.